A-D
2 years ago-Biopharma Group
2 years ago-BioGenes GmbH

IDMP: Back on Track and Bearing Down with New Urgency – What Next?

Views: 103

As EMA renews its focus on ISO IDMP delivery, life sciences organisations targeting European markets must now step up their own measures to ensure they are compliant by 2021. Acknowledging the considerable task ahead of them, Siniša Belina of AMPLEXOR proposes a practical way forward.

Comments: 0

Your email address will not be published. Required fields are marked with *

0

Your Cart